<DOC>
	<DOCNO>NCT00729729</DOCNO>
	<brief_summary>A comparative bioavailability study PCA slow release versus immediate release formulation , single dose fast healthy subject .</brief_summary>
	<brief_title>Pharmacokinetic Study PCA Derivate Formulations</brief_title>
	<detailed_description />
	<criteria>Subjects complete informed consent process culminate write informed consent subject . Males Age 1845 year Abstinence alcohol 1 week prior study Non smoking BMI &gt; 19 &lt; 30 No history evidence significant cardiovascular , hepatic , renal , hematopoietic , gastrointestinal disease , endocrine , metabolic , psychiatric psychological disorder Normal physical examination Within +/ 10 % normal value laboratory examination Subjects suffer current medical condition . Subjects smoke . Subjects drink &gt; 20 gram alcohol per day . Subjects take prescription medication . Subjects abnormality screen blood test Known sensitivity ingredient study drug</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Comparative</keyword>
	<keyword>bioavailability</keyword>
	<keyword>PCA</keyword>
	<keyword>formulation</keyword>
</DOC>